MAPK3 and lung cancer: Conversely, unlike the unchanged ERK1/2 phosphorylation in lung cancer cells [9], BZN repressed the phosphorylation of ERK1/2, and PAM (ERK1/2 activator) partially reversed BZN-induced suppression of proliferation and migration in OS cells.